Thymalin

Thymalin is a low-molecular-weight polypeptide preparation historically derived from thymus tissue. Unlike a conventional synthetic peptide with a single known amino-acid sequence, Thymalin contains multiple short peptide components. Published research has identified short sequences such as Glu-Trp, Lys-Glu, and Glu-Asp-Pro among biologically active components associated with the preparation. This distinction is important because Thymalin should be understood as a thymic peptide complex rather than one discrete molecular entity.

Scientific interest in Thymalin centers largely on its relationship with immune-system regulation. Experimental studies have reported effects on T-lymphocyte differentiation, immune-cell signaling, cytokine-related pathways, gene expression, and hematopoietic cell development. One human-cell study reported changes in markers associated with hematopoietic stem-cell differentiation and increased expression of CD28, a molecule associated with mature T-cell function.

Aging-related research has also examined Thymalin because thymic involution is one component of immunosenescence. Historical clinical studies from Eastern European research groups reported changes in immune, endocrine, metabolic, and health-related outcomes in older adults, although these findings come from a relatively concentrated research tradition and have not been widely replicated through modern independent Western trials. The evidence is therefore scientifically interesting but should be interpreted cautiously.